Talis Biomedical Corp. (TLIS)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 0 |
| Ownership rank: | -- |
| % of all portfolios: | 0% |
| History | Portfolio Manager | Activity | Share change | % change to portfolio ▲ | |
| Q3 2024 | |||||
| ≡ | David Einhorn - Greenlight Capital | Sell 100.00% | 149,052 | 0.06 | |
| Q3 2023 | |||||
| ≡ | David Einhorn - Greenlight Capital | Add 0.00% | 1 | 0.00 | |
| Q2 2023 | |||||
| ≡ | David Einhorn - Greenlight Capital | Reduce 0.00% | 1 | 0.00 | |
| Q1 2022 | |||||
| ≡ | David Einhorn - Greenlight Capital | Add 42.47% | 44,432 | 0.06 | |
| Q4 2021 | |||||
| ≡ | Meridian Contrarian Fund | Sell 100.00% | 22,614 | 0.31 | |
| ≡ | David Einhorn - Greenlight Capital | Buy | 104,620 | 0.38 | |
| Q3 2021 | |||||
| ≡ | Meridian Contrarian Fund | Reduce 29.45% | 9,442 | 0.13 | |
| Q2 2021 | |||||
| ≡ | Meridian Contrarian Fund | Add 26.26% | 6,666 | 0.15 | |
| Q1 2021 | |||||
| ≡ | Meridian Contrarian Fund | Buy | 25,388 | 0.71 | |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.